Linkedin
Facebook
Twitter
Youtube

23 Feb Bone Therapeutics

Posted at 18:52h in by

Anthony Ting, Ph.D., Chief Scientific Officer

Oct. 13 | 10:00am | BlueRock Therapeutics Ballroom

Gosselies, Belgium
(NASDAQ: BOTHE)

In-person Presentation
Bone Therapeutics is a listed, clinical-stage, cell therapy company committed to rebuilding the lives of patients suffering from debilitating bone and joint conditions. Leveraging its extensive expertise in mesenchymal stromal cells (MSCs), bone physiology, and patented manufacturing technology, Bone Therapeutics is developing a commercially ready, allogeneic, and off-the-shelf bone cell therapy platform, ALLOB, and a next-generation improved viscosupplement for osteoarthritic pain, JTA-004, which are designed to offer patients and physicians best-in-class treatment options. Currently in Phase II/III clinical development, Bone Therapeutics’ advanced product portfolio targets large orthopedic conditions with high unmet needs, such as knee osteoarthritis, unhealed fractures, and spinal fusion. Building on its allogeneic MSC platform, Bone Therapeutics recently broadened the product portfolio from orthopedics into inflammatory and other conditions.
www.bonetherapeutics.com



About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 11-13, 2022
Carlsbad, CA

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions